Search

everythinglearnresearchcommunity

for

Search:↓

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Minoxidil activation by hair enzymes predicts treatment success for female hair loss.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Shi-Bi-Man activates hair follicle stem cells and promotes hair growth by changing lactic acid metabolism and other cellular processes.

Integrin β1 is crucial for liver structure and function, preventing fibrosis.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Wnt/ß-catenin signaling is crucial for regulating skin stem cells and hair growth, with the right levels and timing needed for proper function.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Immune cells affect hair growth and could lead to new hair loss treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Lower SMAD2/3 activation predicts more severe skin cancer.